Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas

Carcinogenesis

Volumn 22, Issue 7, 2001, Pages 1049-1052

  Fukushima, Hiroshi ^a   Yamamoto, Hiroyuki ^a   Itoh, Fumio ^a   Nakamura, Hideaki ^a   Min, Yongfen ^a   Horiuchi, Shina ^a   Iku, Shouhei ^a   Sasaki, Shigeru ^a   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; CORRELATION FUNCTION; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME;

ADENOCARCINOMA; BASE SEQUENCE; DNA PRIMERS; GENES, RAS; HUMANS; MATRIX METALLOPROTEINASE 7; MUTATION; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0034929252     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.7.1049     Document Type: Article

References (40)

1. Matrilysin: An epithelial matrix metalloproteinase with potentially novel functions
2. Changing views of the role of matrix metalloproteinases in metastasis
3. Matrilysin
4. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice
5. Suppression of matrilysin inhibits colon cancer cell invasion in vitro
6. Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells
7. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers
8. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis
9. Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers
10. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma
11. Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma
12. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenecity in vivo
13. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin
14. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis
15. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis
16. Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin
17. Matrilysin gene expression in sporadic and familial colorectal adenomas
18. Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas
19. Matrilysin is associated with progression of colorectal tumor
20. Matrix metalloproteinase-7 expression in gastric carcinoma
21. Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer
22. Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma
23. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma
24. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors
25. β-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer
26. Analysis of β-catenin gene mutations in pancreatic tumors
27. Mutations of the adenomatous polyposis coli gene in the mutation cluster region: Comparison of human pancreatic and colorectal cancers
28. Structure and expression of the human gene for the matrix metalloproteinase matrilysin
29. Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells
30. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity
31. TNM classification of malignant tumors
32. Modulation of matrix metalloproteinase-7 (matrilysin) secretion in coculture of human colon carcinoma cells with fibroblasts from orthotopic and ectopic organs
33. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle
34. Degradation of entactin by matrix metalloproteinase. Susceptibility to matrilysin and identification of cleavage sites
35. Processing of tumour necrosis factor-α precursor by metalloproteinases
36. Diphtheria toxin endocytosis and membrane translocation are dependent on the intact membrane-anchored receptor (HB-EGF precursor): Studies on the cell-associated receptor cleaved by a metalloprotease in phorbol-ester-treated cells
37. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
38. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma
39. Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas
40. The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer